Effects of Pioglitazone [Actos] on the Regulation of Insulin Secretion in Patients With Type 2 Diabetes.
Phase of Trial: Phase IV
Latest Information Update: 26 Jun 2018
At a glance
- Drugs Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 26 Jun 2018 Results assessing the changes in cargo composition of circulating exosomes as biomarkers of Pioglitazone response, presented at the 78th Annual Scientific Sessions of the American Diabetes Association
- 17 Feb 2016 Results of this and other trial published in the Obesity (Silver Spring, Md.)
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.